Efficacy and tolerability of intravenous ferric gluconate in the treatment of iron deficiency anemia in patients without kidney disease.
Miller
Heather J
HJ
Hu
James
J
Valentine
Johanna K
JK
Gable
Preston S
PS
D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage*; D005293:Ferritins / Q000097:blood; D005500:Follow-Up Studies; D006397:Hematinics / Q000008:administration & dosage*; D006400:Hematocrit; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007262:Infusions, Intravenous; D007674:Kidney Diseases; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome
D005290:Ferric Compounds; D006397:Hematinics; D006454:Hemoglobins; D005293:Ferritins; C035552:ferric gluconate